Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Schmid John P. (CIK 1478916) reported 9 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-08-10). Recent activity: Buy BLSM (6,000 shares), Buy ANAB (6,030 shares), Buy TRAX (6,030 shares), Sell ANAB (12,596 shares), Sell ANAB (7,527 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | BlossomHill Therapeutics, Inc. (BLSM) | Director | Buy | 6,000 | $96,000 |
| 2026-06-17 | ANAPTYSBIO, INC (ANAB) | Director | Buy | 6,030 | $0 |
| 2026-06-17 | First Tracks Biotherapeutics, Inc. (TRAX) | Director | Buy | 6,030 | $0 |
| 2026-04-01 | ANAPTYSBIO, INC (ANAB) | Director | Sell | 12,596 | $701,723 |
| 2026-04-01 | ANAPTYSBIO, INC (ANAB) | Director | Sell | 7,527 | $426,781 |
| 2026-04-01 | ANAPTYSBIO, INC (ANAB) | Director | Sell | 522 | $29,963 |
| 2025-12-23 | ANAPTYSBIO, INC (ANAB) | Director | Sell | 11,068 | $564,468 |
| 2025-08-11 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Insider | Buy | 30,000 | $0 |
| 2025-06-17 | ANAPTYSBIO, INC (ANAB) | Director | Buy | 6,030 | $0 |
Source: SEC Form 4 filings · as of 2026-08-10